Author: Chi Heem Wong; Kien Wei Siah; Andrew W Lo
Title: Estimating Probabilities of Success of Clinical Trials for Vaccines and Other Anti-Infective Therapeutics Document date: 2020_4_14
ID: fnrm6a79_20
Snippet: Across all industry-sponsored vaccine development programs, we can see that monkeypox vaccines have had the most developmental success, followed by rotavirus and Japanese encephalitis vaccines (see Figure 3) . Their overall success rates are 100% (SE: 0%), 78.7% (SE: 5.2%), and 67.6% (SE: 8.0%), respectively. The PoS for monkeypox is based on only one sample. Only 12 diseases out of the 27 disease categories with at least one development path obs.....
Document: Across all industry-sponsored vaccine development programs, we can see that monkeypox vaccines have had the most developmental success, followed by rotavirus and Japanese encephalitis vaccines (see Figure 3) . Their overall success rates are 100% (SE: 0%), 78.7% (SE: 5.2%), and 67.6% (SE: 8.0%), respectively. The PoS for monkeypox is based on only one sample. Only 12 diseases out of the 27 disease categories with at least one development path observed have seen at least one approved vaccine.
Search related documents:
Co phrase search for related documents- development path and industry sponsor: 1
- development path and vaccine development: 1, 2, 3, 4, 5, 6
- developmental success and vaccine development: 1, 2
- disease category and vaccine development: 1, 2
- encephalitis vaccine and japanese encephalitis vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- encephalitis vaccine and vaccine development: 1, 2, 3, 4, 5
- industry sponsor and vaccine development: 1
- japanese encephalitis vaccine and vaccine development: 1, 2
- overall success rate and success rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- respectively SE and vaccine development: 1, 2, 3, 4
- respectively SE SE and vaccine development: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date